|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06618 JD HEALTH
Nominal 
40.600 +2.950 (+7.835%) | 2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Turnover | 27,110,336 | 34.042% | 46,736,150 | 30,682,267 | 19,382,568 | 10,842,140 | |
| Cost of Sales | (20,907,336) | 32.236% | (36,844,642) | (23,484,985) | (14,465,270) | (8,029,868) | |
| Gross Profit | 6,203,000 | 40.512% | 9,891,508 | 7,197,282 | 4,917,298 | 2,812,272 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (64,662) | 486.503% | (98,202) | (38,352) | (17,539,975) | (1,264,989) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (32,197) | -33.705% | (96,759) | (94,165) | (77,024) | 0 | |
| Profit / (Loss) before Taxation | 1,831,226 | 385.291% | 695,809 | (901,491) | (17,072,141) | (834,700) | |
| Taxation | (269,234) | 74.388% | (312,580) | (171,327) | (162,756) | (137,105) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (634) | -- | (3,124) | (689) | 534 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,561,358 | 598.432% | 380,105 | (1,073,507) | (17,234,363) | (971,805) | |
| Net Finance Costs / (Income) | (932,068) | 331.973% | (855,167) | (451,570) | (145,700) | 3,719 | |
| Depreciation & Amortisation | 107,930 | 111.694% | 140,676 | 63,169 | 27,221 | 7,423 | |
| Directors' Emoluments | -- | -- | -- | 1,062,758 | 296,370 | 19,345 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 50.000 | -- | 12.000 | -35.000 | -780.000 | -45.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | 1.109 | 1.675 | 0.191 |
| NBV per share ($) | 15.309 | -- | 14.082 | 12.475 | 12.326 | -- |
| Remarks: | Real time quote last updated: 29/09/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,561,358 |
| %Change | 598.432% |
| EPS / (LPS) | RMB 0.500 |
| NBV Per Share (¥) | RMB 15.309 |